Morgan Stanley Maintains Overweight on IDEXX Laboratories, Raises Price Target to $810
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsPrice TargetHot
Morgan Stanley analyst Erin Wright maintains IDEXX Laboratories (NASDAQ:IDXX) with a Overweight and raises the price target from $805 to $810.
Morgan Stanley analyst Erin Wright maintains IDEXX Laboratories (NASDAQ:IDXX) with a Overweight and raises the price target from $805 to $810.